SinoCellTech Ltd.
3Patents
3Active
3Granted
57Portfolio score
Filing activity: Jun 21, 2021 → Jan 19, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12060416B2 | Humanized anti-VEGF monoclonal antibody | Chemistry; Metallurgy | 0 | Active |
| US12139514B2 | Chimeric papilloma virus L1 protein | Chemistry; Metallurgy | 0 | Active |
| US12275790B2 | Humanized anti-PD-1 antibody and the use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.